National Research (NRCIB) Given Daily Media Sentiment Rating of 0.04

Headlines about National Research (NASDAQ:NRCIB) have been trending somewhat positive on Friday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. National Research earned a media sentiment score of 0.04 on Accern’s scale. Accern also assigned news headlines about the business services provider an impact score of 45.3184557855572 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

National Research (NASDAQ:NRCIB) opened at $55.92 on Friday. The stock has a market cap of $1,365.85, a PE ratio of 78.58 and a beta of 0.07. National Research has a one year low of $38.76 and a one year high of $58.16.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 12th. Stockholders of record on Friday, December 29th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 4.29%. The ex-dividend date of this dividend is Thursday, December 28th. National Research’s dividend payout ratio (DPR) is presently 480.00%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/3126579/national-research-nrcib-given-daily-media-sentiment-rating-of-0-04.html.

National Research Company Profile

National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Insider Buying and Selling by Quarter for National Research (NASDAQ:NRCIB)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.